Second and Third Generational Advances in Therapies of the Immune-Mediated Kidney Diseases in Children and Adolescents

Therapy of immune-mediated kidney diseases has evolved during recent decades from the non-specific use of corticosteroids and antiproliferative agents (like cyclophosphamide or azathioprine), towards the use of more specific drugs with measurable pharmacokinetics, like calcineurin inhibitors (cyclos...

Descripción completa

Detalles Bibliográficos
Autores principales: Grenda, Ryszard, Obrycki, Łukasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030090/
https://www.ncbi.nlm.nih.gov/pubmed/35455580
http://dx.doi.org/10.3390/children9040536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030090/
https://www.ncbi.nlm.nih.gov/pubmed/35455580
http://dx.doi.org/10.3390/children9040536

Ejemplares similares